AnteoTech
AnteoTech is an Australian (ASX: ADO) materials and diagnostics company that develops silicon anode battery technologies (UltraNode, Anteo X, Anteo S) for drone, defense, and medical device applications, and AnteoBind diagnostic binding products for healthcare, agriculture, and veterinary markets, selling via channel partners globally.
- Company typePublic
- Founded1995
- HeadquartersEight Mile Plains, Australia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What AnteoTech does
AnteoTech Ltd (ASX: ADO) is a Brisbane-based public company founded in 1995 that operates two distinct technology platforms. In Life Sciences it develops and commercializes diagnostic binding products under the AnteoBind brand, including the next-generation AnteoBind NXT platform expanded into chemiluminescence, serving healthcare, agriculture, and veterinary diagnostics customers such as the Serum Institute. In Advanced Battery Technologies it develops UltraNode silicon anode materials (notably UltraNode 95, with stated capacities of 2,000-2,400 mAh/g versus ~371 mAh/g for graphite, enabling energy densities above 390 Wh/kg), the Anteo X platform, and the Anteo S cross-linking separator product, with go-to-market focus on drone, defense, and medical device battery applications and recent independent validation by the Battery Innovation Center in Indiana. Revenue mechanics combine product sales (AnteoBind diagnostics), licensing/royalty arrangements (battery materials with partners such as Xerobrid), and an end-to-end contract services offering, distributed through a small but expanding network of channel partners including Cosmo Bio in Japan, Black Diamond Structures in the US, and South Korean battery distributors.
The company is small (11-50 employees), headquartered at Brisbane Technology Park in Eight Mile Plains, and has undergone cost-base restructuring alongside an AUD 3.5 million capital raise in early 2026 to extend operational runway and accelerate sales conversion. Strategic activity in mid-2026 has centred on commercialization: an UltraNode 95 product launch, a strategic collaboration with Xerobrid Corporation pairing Anteo S with ceramic-coated separators, a Cosmo Bio distribution deal opening Japan, and JDAs being negotiated with US defense-aligned battery manufacturers. The current share price sits near 52-week lows at AUD 0.012, reflecting investor concern about the speed of revenue conversion, while named partners and validation milestones support an active commercialization pipeline.
AnteoTech firmographics
Firmographics- Name
- AnteoTech
- Legal name
- AnteoTech Ltd
- Website
- https://anteotech.com
- Company type
- Public
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- AnteoTech is an Australian (ASX: ADO) materials and diagnostics company that develops silicon anode battery technologies (UltraNode, Anteo X, Anteo S) for drone, defense, and medical device applications, and AnteoBind diagnostic binding products for healthcare, agriculture, and veterinary markets, selling via channel partners globally.
- Ownership category
- akta.pro rank
Where AnteoTech is headquartered
LocationHeadquarters
- HQ city
- Eight Mile Plains
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
AnteoTech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Battery Technology Products: Revenue from battery separator technology (Anteo S) and silicon anode products (UltraNode). Strategic collaboration and sales agreement with Xerobrid Corporation for separator technology.
- Life Sciences Diagnostics: Revenue from diagnostic products including AnteoBind and AnteoBind NXT, with expansion into chemiluminescence market. Serum Institute order mentioned as key revenue catalyst.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
AnteoTech product offering
Product offeringCore offering
AnteoTech develops and commercializes two technology platforms: (1) Advanced Battery Technologies, including silicon anode materials (Ultranode/UltraNode 95), a battery technology platform (Anteo X), and a cross-linking separator product (Anteo S); and (2) Life Sciences diagnostics, including the AnteoBind platform and next-generation AnteoBind NXT for chemiluminescence-based in vitro diagnostics, alongside end-to-end Contract Services for diagnostics product realization.
Product overview
AnteoTech is a Brisbane-based company (ASX: ADO) operating across two distinct technology platforms: Life Sciences and Advanced Battery Technologies. In Life Sciences, the company offers AnteoBind as its core diagnostic brand, with AnteoBind NXT representing next-generation development expanding into chemiluminescence. Contract Services support end-to-end product realization. In Advanced Battery Technologies, Anteo X serves as the foundational battery technology platform, while Ultranode™ (including UltraNode 95 and Ultranode X variants) provides silicon anode solutions for enhanced energy density. Anteo S represents a cross-linking separator product for battery safety applications.
Differentiator
Problem solved
Functional benefit
Brands
- Anteo X: Advanced battery technology product line
- Ultranode
- AnteoBind
- AnteoBind NXT
Products and services
- Anteo X Advanced battery technology platform that enables manufacturing partners to build lighter, more compact and cost-effective lithium-ion batteries. Targeted at lithium-ion battery manufacturers.
- Ultranode (UltraNode 95) Silicon anode technology for lithium-ion batteries delivering significantly higher energy densities than conventional graphite anodes. UltraNode 95 achieves approximately 2,000-2,400mAh/g vs graphite's ~371mAh/g limit. Targeted at battery manufacturers serving drone, defense, EV and medical device applications.
- AnteoBind Proprietary diagnostic binding technology platform enabling niche and novel diagnostic products addressing global challenges in healthcare, agriculture and veterinary sciences. Targeted at diagnostic manufacturers and life sciences companies.
- AnteoBind NXT Next-generation diagnostic product development expanding into the chemiluminescence market for in vitro diagnostics, delivering improved speed and accuracy in healthcare diagnostics. Targeted at diagnostic assay developers and immunoassay manufacturers.
- Contract Services End-to-end contract services spanning initial product concept through to successful product realization and distribution for diagnostics and life sciences. Targeted at life sciences companies seeking outsourced product development support.
- Anteo S Cross-linking Separator Cross-linking separator product combined with ceramic coated separator technology to improve lithium-ion battery safety and performance. Targeted at lithium-ion battery manufacturers globally.
Quantifiable outcome
- Energy density above 390Wh/kg for lithium-ion batteries
- +2 more outcomes
Companies that use AnteoTech
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
AnteoTech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
AnteoTech partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Cosmo BiocoreTokyo-listed Cosmo Bio appointed as Japanese distributor for AnteoBind products, targeting growth in the immunoassay market. Distribution deal opens Japan sales channel.
- Xerobrid CorporationcoreStrategic collaboration and sales agreement combining AnteoTech's Anteo S cross-linking separator product with Xerobrid's ceramic coated separator technology to improve battery safety and performance. Four companies in South Korea are currently evaluating Anteo S for integration and scale-up, with a comprehensive three-year agreement expected within 120 days.
- Black Diamond StructuresminorMarket expansion partnership with Black Diamond Structures in the US for battery sector distribution.
- South Korean DistributorsminorDistribution partners in South Korea for battery market expansion.
- Battery Innovation Center (Indiana)coreIndependent validation of UltraNode 95 silicon anode technology confirming integration into existing manufacturing processes without major changes, supporting pathway toward cost-effective commercial production.
- WyonminorTrial of Ultranode for high-value medical device battery market targeting.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
AnteoTech competitors and assessment
Company assessmentDirect peers
- Enovix Corporation: 100% active silicon 3D-cell architecture for high energy-density lithium-ion batteries, targeting consumer electronics and EVs. Comparable to AnteoTech on silicon-based energy-density leadership and pursued licensing/manufacturing partnerships with Tier-1 players.
- Amprius Technologies: US-listed silicon anode battery company targeting defense, drone and aviation markets with high energy-density cells. Closest functional comparable to AnteoTech's UltraNode 95 silicon anode offering on technology, customer profile (defense OEMs) and performance metric (Wh/kg).
- Sila Nanotechnologies: Developer of silicon-dominant anode materials for lithium-ion batteries serving automotive and consumer electronics. Directly comparable to AnteoTech on silicon anode chemistry, drop-in manufacturing approach, and licensing-style commercial model.
- Group14 Technologies: Silicon battery materials company producing silicon-carbon anode powders for automotive and consumer battery applications. Direct materials-level peer to AnteoTech's UltraNode silicon anode active material strategy.
- Enevate Corporation: Silicon-dominant anode technology for fast-charging, high energy-density Li-ion batteries, primarily serving EV applications. Closely comparable to AnteoTech on silicon anode IP and on a partner-licensed commercialization model.
Broad incumbents
- Revvity: Spun-off life sciences and diagnostics business (formerly PerkinElmer) covering immunoassays, chemiluminescence platforms and reagents used across clinical diagnostics. Directly comparable to AnteoBind NXT's chemiluminescence expansion strategy.
- Bio-Techne Corporation: Large global developer of life-sciences research reagents and diagnostic tools including proteins, antibodies and assays. Comparable to AnteoTech's AnteoBind diagnostic reagents/IVD business on customer base (research and diagnostic labs) and product category (binding reagents).
- Abcam (Danaher): Global supplier of protein research tools, antibodies and diagnostic binding reagents, now part of Danaher. Comparable to AnteoTech's AnteoBind diagnostic binding technology on customer overlap (research/diagnostic labs) and binding-reagent product positioning.
- QuidelOrtho: Global diagnostics company with broad immunoassay and clinical chemistry menu, including chemiluminescence-based platforms. Comparable to AnteoTech's diagnostic expansion strategy serving clinical labs and reference laboratories worldwide.
Emerging players
- NEO Battery Materials: Canadian-listed developer of silicon anode materials for lithium-ion batteries with focus on cost-effective manufacturing processes. Comparable emerging player to AnteoTech on silicon anode chemistry and on partnering with cell manufacturers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
AnteoTech social profiles
Digital presenceAnteoTech financial estimates
Financial estimateRevenue estimate
Valuation estimate
AnteoTech leadership team
Management profileNumber of profiles
Profiles2 records
AnteoTech funding detail
Funding detailFunding overview
Funding rounds4 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AnteoTech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AnteoTech
What does AnteoTech do?
AnteoTech develops and commercializes two technology platforms: (1) Advanced Battery Technologies, including silicon anode materials (Ultranode/UltraNode 95), a battery technology platform (Anteo X), and a cross-linking separator product (Anteo S); and (2) Life Sciences diagnostics, including the AnteoBind platform and next-generation AnteoBind NXT for chemiluminescence-based in vitro diagnostics, alongside end-to-end Contract Services for diagnostics product realization.
Is AnteoTech a public or private company?
AnteoTech is a public company. It is classified as public and is currently operating.
When was AnteoTech founded?
AnteoTech was founded in 1995. It employs 11 to 50 people.
Where is AnteoTech based?
AnteoTech is headquartered in Eight Mile Plains, Australia, in the Oceania region.
How does AnteoTech make money?
Two revenue lines are on record. Battery Technology Products are the primary driver. The others are life Sciences Diagnostics.
Who are AnteoTech's main competitors?
Direct peers on record are Enovix Corporation, Amprius Technologies, Sila Nanotechnologies, Group14 Technologies and Enevate Corporation. Broad incumbents are Revvity, Bio-Techne Corporation, Abcam (Danaher) and QuidelOrtho. NEO Battery Materials is listed as an emerging player.
Does AnteoTech have an API?
No public API is recorded for AnteoTech.